Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dolby Laboratories (DLB) EPS (Weighted Average and Diluted) (2016 - 2025)

Dolby Laboratories' EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $0.55 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 21.43% year-over-year to $0.55; the TTM value through Dec 2025 reached $2.48, down 8.49%, while the annual FY2025 figure was $2.62, 2.6% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.55 in Q4 2025 per DLB's latest filing, up from $0.51 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.01 in Q1 2024 to a low of $0.09 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.57, with a median of $0.54 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 68.97% in 2023, then surged 566.67% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.77 in 2021, then rose by 6.49% to $0.82 in 2022, then decreased by 15.85% to $0.69 in 2023, then rose by 1.45% to $0.7 in 2024, then decreased by 21.43% to $0.55 in 2025.
  • Per Business Quant, the three most recent readings for DLB's EPS (Weighted Average and Diluted) are $0.55 (Q4 2025), $0.51 (Q3 2025), and $0.48 (Q2 2025).